Lymphoblastic Lymphoma — Trials

Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 37%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05602194	Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	active not recruiting	Phase 3	440	Children's Oncology GroupNETWORK	2	Aug 21, 2026	clinicaltrials
NCT03914625	A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia	active not recruiting	Phase 3	6,720	National Cancer Institute (NCI)NIH	5	Jul 30, 2026